Green Thumb Industries GTBIF
OTC GTBIF
$7.67 +0.16 (+2.13%)
As of: Aug 21, 2026 · 3:59 PM EDT

Green Thumb Industries (GTBIF) Other Non-Current Liabilities (2019 - 2026)

Green Thumb Industries' (GTBIF) quarterly Other Non-Current Liabilities came in at $33.2 million in Q4 2023, up 16525.0% YoY from N/an in Q4 2022, and up 6.32% on a QoQ basis from $31.3 million in Q1 2023.

Green Thumb Industries (GTBIF) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends

Green Thumb Industries (GTBIF) has 5 years of Other Non-Current Liabilities data on file, last reported at $33.2 million in Q4 2023.

  • Quarterly Other Non-Current Liabilities rose 16525.0% year-over-year to $33.2 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $33.2 million (up 16525.0% YoY) and the FY2023 annual result came in at $33.2 million, up 16525.0% from the prior year.
  • Other Non-Current Liabilities climbed to $33.2 million in Q4 2023, from $31.3 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $98.5 million in Q4 2021 to a low of $200000.0 in Q3 2022.
  • A 5-year average of $30.1 million and a median of $24.1 million in 2022 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Other Non-Current Liabilities plunged 99.8% — and 2023, when it surged 16525.0%.
  • Tracing GTBIF's Other Non-Current Liabilities over 5 years: stood at $57.0 million in 2019, then sank by 83.83% to $9.2 million in 2020, then soared by 968.87% to $98.5 million in 2021, then sank by 99.8% to $200000.0 in 2022, then surged by 16525.0% to $33.2 million in 2023.
  • The last three Other Non-Current Liabilities figures came in at $33.2 million (Q4 2023), $31.3 million (Q1 2023), and $200000.0 (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Green Thumb Industries 1.69 Bn 1.41 Bn 137.87 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 203.45 Mn
Dec 31, 2025 203.45 Mn
Dec 31, 2023 33.25 Mn
Mar 31, 2023 31.27 Mn
Dec 31, 2022 200,000.00
Sep 30, 2022 200,000.00
Jun 30, 2022 3.11 Mn
Mar 31, 2022 16.95 Mn
Dec 31, 2021 98.50 Mn
Sep 30, 2021 61.85 Mn
Jun 30, 2021 47.46 Mn
Mar 31, 2021 45.30 Mn
Sep 30, 2020 9.22 Mn
Jun 30, 2020 8.99 Mn
Mar 31, 2020 8.50 Mn
Dec 31, 2019 56.99 Mn